Caxton »

Inhibikase Therapeutics shares owned by Caxton

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Caxton from 13F filings

Historical chart of Caxton investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Caxton

Quarter filed Position value Share count Share price at filing
2025-09-30 $27k 16k 1.62
2025-06-30 $32k 16k 1.95
2025-03-31 $36k 16k 2.19
2024-12-31 $53k 16k 3.25